Shufro Rose & CO LLC Gsk PLC Transaction History

Shufro Rose & CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$42.05 - $47.77 $255,117 - $289,820	6,067 New	6,067 $264,000
Q1 2019 May 03, 2019	SELL	$38.57 - $42.69 $337,487 - $373,537	-8,750 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$39.75 - $42.69 $35,775 - $38,421	-900 Reduced 9.33%	8,750 $351,000
Q2 2018 Jul 27, 2018	BUY	$39.61 - $42.76 $26,657 - $28,777	673 Added 7.5%	9,650 $389,000
Q4 2017 Feb 06, 2018	BUY	$35.34 - $41.9 $8,022 - $9,511	227 Added 2.59%	8,977 $318,000
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $345,100 - $363,562	8,750	8,750 $355,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Shufro Rose & CO LLC with notifications on news.